Streetbeat News

Price Targets

EWBC

Truist Securities analyst Brandon King has reaffirmed a Buy rating on East West Bancorp (NASDAQ:EWBC) and increased the price target from $62 to $83.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 3:25 pm

HEI

HEICO Corporation (NYSE:HEI) is expected to report lower Q4 earnings at 68 cents per share compared to 70 cents per share a year ago. Revenue is projected to be $908.34 million, up from $609.64 million. The company previously reported a 27% year-over-year revenue increase in Q3. HEICO shares recently fell 1.6% to $183.01. Analysts from Deutsche Bank, Benchmark, Baird, Morgan Stanley, and B of A Securities have provided various ratings and price targets for HEICO, with accuracy rates ranging from 62% to 82%.

Portfolio Pulse from Avi Kapoor

December 15, 2023 | 3:22 pm

EXC

Exelon's stock (EXC) trades lower following a downgrade from Buy to Neutral by Guggenheim, with a new price target set at $40.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 3:20 pm

COST

Oppenheimer analyst Rupesh Parikh has reiterated an Outperform rating on Costco Wholesale (NASDAQ:COST) and maintained a price target of $675.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 3:14 pm

COHR

Raymond James analyst Simon Leopold has maintained an Outperform rating on Coherent (NYSE:COHR) and increased the price target from $42 to $53.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 3:05 pm

COST

Raymond James analyst Bobby Griffin has maintained an Outperform rating on Costco Wholesale (NASDAQ:COST) and increased the price target from $580 to $670, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 3:02 pm

TER

Over the past 3 months, 4 Wall Street analysts have published their opinions on Teradyne (NASDAQ:TER), with an average price target of $107.25, representing an implied upside from the current price of $104.39. The current average target has decreased by 12.45% from the previous target of $122.50. Ratings are distributed across bullish, somewhat bullish, indifferent, and somewhat bearish, with no bearish ratings. Analysts rate stocks based on company performance predictions and provide guidance on stocks quarterly or after major updates.

Portfolio Pulse from Benzinga Insights

December 15, 2023 | 3:01 pm

AKAM

Over the past 3 months, 10 Wall Street analysts have provided ratings for Akamai Technologies (NASDAQ:AKAM), with an average price target of $116.3, which is below the current price of $118.65. The ratings include 1 bullish, 3 somewhat bullish, 5 indifferent, and 1 somewhat bearish. The average price target has increased by 14.18% over the past month.

Portfolio Pulse from Benzinga Insights

December 15, 2023 | 3:01 pm

DRTS

Alpha Tau Medical (NASDAQ:DRTS) received 4 analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish, and no bearish ratings. The average 12-month price target is $8.5, with a high of $9.00 and a low of $8.00, representing a 29.17% decrease from the previous target of $12.00. Analysts use various methods to determine their ratings, which are opinions and can vary.

Portfolio Pulse from Benzinga Insights

December 15, 2023 | 3:01 pm

CL

Colgate-Palmolive (NYSE:CL) received 11 analyst ratings in the last quarter, with an average 12-month price target of $82.64, a decrease from the previous $84.88. Ratings are bullish to indifferent, with no bearish outlooks. Analysts' opinions are based on various data sources and provide guidance to investors.

Portfolio Pulse from Benzinga Insights

December 15, 2023 | 3:00 pm